Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty.

Jacobs JJ, Mont MA, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AC Jr, Boggio LN, Watters WC 3rd, Turkelson CM, Wies JL, Sluka P, Hitchcock K.

J Bone Joint Surg Am. 2012 Apr 18;94(8):746-7. doi: 10.2106/JBJS.9408.ebo746. No abstract available.

PMID:
22517391
2.

Prevention of VTE Following total hip and knee arthroplasty in Hemophilia patients.

Stein MI, Park J, Raterman S.

Orthopedics. 2011 May;34(5):393. doi: 10.3928/01477447-20110317-21. Review.

PMID:
21553745
3.
4.

Prevention of venous thromboembolic disease after total hip and knee arthroplasty.

Lieberman JR, Pensak MJ.

J Bone Joint Surg Am. 2013 Oct 2;95(19):1801-11. doi: 10.2106/JBJS.L.01328. Review.

PMID:
24088973
5.

Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.

Dager WE.

Ann Pharmacother. 2012 Jan;46(1):79-88. doi: 10.1345/aph.1P626. Epub 2011 Dec 27. Review.

PMID:
22202495
6.

Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.

Friedman RJ, Sengupta N, Lees M.

Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):299-306. doi: 10.1586/erp.11.15. Review.

PMID:
21671699
7.

Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns.

Fisher WD, Turpie AG.

CMAJ. 2008 Jun 3;178(12):1571-2. doi: 10.1503/cmaj.080507. Review. No abstract available.

PMID:
18519905
8.

A Current Review of Mechanical Compression and Its Role in Venous Thromboembolic Prophylaxis in Total Knee and Total Hip Arthroplasty.

Pierce TP, Cherian JJ, Jauregui JJ, Elmallah RK, Lieberman JR, Mont MA.

J Arthroplasty. 2015 Dec;30(12):2279-84. doi: 10.1016/j.arth.2015.05.045. Epub 2015 May 29. Review.

PMID:
26048728
9.

Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.

Pellegrini VD Jr, Sharrock NE, Paiement GD, Morris R, Warwick DJ.

Instr Course Lect. 2008;57:637-61. Review.

PMID:
18399613
10.

Understanding the RECORDS 3 Trial and its impact on anticiagulation practice in resource poor countries.

Nwagha TU, Omunakwe HE.

Niger J Clin Pract. 2016 Nov-Dec;19(6):695-699. doi: 10.4103/1119-3077.180059. Review.

PMID:
27811436
11.

Never events and related quality measures following total hip and total knee replacement.

Kwong LM.

Orthopedics. 2010 Nov;33(11):838. Review. No abstract available.

PMID:
21155137
12.

Quality improvement program: advancement of hospital venous thromboembolism--free zones.

Merli G.

Am J Manag Care. 2011 Feb;17(1 Suppl):S9-14. Review.

PMID:
21517655
13.

Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.

Kwong LM.

Am J Manag Care. 2011 Feb;17(1 Suppl):S22-6. Review.

PMID:
21517652
14.

[The new guidelines for deep venous thromboembolic disease prophylaxis in elective hip and knee replacement surgery. Are we nearer or further away from a consensus?].

Ruiz-Iban MA, Díaz-Heredia J, Elías-Martín ME, Martos-Rodríguez LA, Cebreiro-Martínez del Val I, Pascual-Martín-Gamero FJ.

Rev Esp Cir Ortop Traumatol. 2012 Jul-Aug;56(4):328-37. doi: 10.1016/j.recot.2012.04.002. Epub 2012 Jun 2. Review. Spanish.

PMID:
23594854
15.

[Prophylaxis of venous thromboembolism in orthopedic surgery].

Giuseppini MU, Guiducci S, Bardelli M.

Minerva Med. 2010 Feb;101(1):49-58. Review. Italian.

PMID:
20228720
16.

Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.

Stevenson M, Scope A, Holmes M, Rees A, Kaltenthaler E.

Health Technol Assess. 2009 Oct;13 Suppl 3:43-8. doi: 10.3310/hta13suppl3/07. Review.

PMID:
19846028
17.

[SECOT consensus on thromboembolisms in knee and hip replacement surgery].

Castellet E, Peidró L, Otero R.

Rev Esp Cir Ortop Traumatol. 2013 Mar-Apr;57(2):150-9. doi: 10.1016/j.recot.2013.01.003. Epub 2013 Mar 9. Spanish.

PMID:
23608217
18.

Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.

Eriksson BI, Friedman RJ.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:25S-31S. doi: 10.1177/1076029609340668. Epub 2009 Jul 31. Review.

PMID:
19648146
19.

Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence.

Stewart DW, Freshour JE.

Ann Pharmacother. 2013 Jan;47(1):63-74. doi: 10.1345/aph.1R331. Epub 2013 Jan 16. Review.

PMID:
23324504
20.

Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgery.

Mahan CE, Kaatz S.

Pharmacotherapy. 2012 Nov;32(11):1036-48. doi: 10.1002/phar.1133. Review.

PMID:
23124723

Supplemental Content

Support Center